Sarcoidosis in Israel: Clinical Outcome Status, Organ Involvement, and Long-Term Follow-Up
- 15 May 2017
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 195 (4) , 419-424
Abstract
Sarcoidosis is a chronic granulomatous inflammatory disease of unknown etiology with heterogeneous outcomes. This study reviewed the clinical outcome status (COS) and organ involvement of Israeli sarcoidosis patients during a five-year period. Further, we compared our results to the ‘World Association of Sarcoidosis and Other Granulomatous Disease’ (WASOG) COS and the ‘A Case Control Etiologic Study of Sarcoidosis’ (ACCESS) instruments in order to evaluate their relevance to the Israeli population.Keywords
This publication has 23 references indexed in Scilit:
- Morbidity and mortality in sarcoidosisCurrent Opinion in Pulmonary Medicine, 2014
- Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force.2011
- Sarcoidosis Around the WorldClinics in Chest Medicine, 2008
- Diagnosis of sarcoidosisCurrent Opinion in Pulmonary Medicine, 2008
- Erythema nodosum: an evaluation of 100 cases.2007
- The Diagnostic Pathway to Sarcoidosis*Chest, 2003
- Sarcoidosis: Impact of Other Illnesses on the Presentation and Management of Multi-Organ DiseaseLung, 2002
- Clinical Characteristics of Patients in a Case Control Study of SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Statement on SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Pulmonary SarcoidosisNew England Journal of Medicine, 1981